Julie Parsonnet is Professor, Stanford University at Stanford University. OpenAlex indexes 363 publications with 24,023 citations (h-index 69); ClinicalTrials.gov lists 9 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Infectious Disease profiles in the findmyKOL directory.
Data verified 21 Oct 2026
Overview
Updated 21 Oct 2026
Julie Parsonnet, M.D., is Professor, Stanford University. The public record shows 363 publications with 24,023 citations (h-index 69), centered on Helicobacter pylori-related gastroenterology studies, Gastric Cancer Management and Outcomes, SARS-CoV-2 and COVID-19 Research. It also documents an investigator role on 9 registered clinical trials, 20 NIH-funded awards (1991–2026).
- Most recent indexed publication: 2026 · Science (New York, N.Y.)
- Top research focus: Helicobacter pylori-related gastroenterology studies
- 9 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 21 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 26 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 186.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 21 Oct 2026
Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:
- Laboratory Heat Biomarker and Cooling Interventions
Sponsor: Stanford University
- SARS-COV-2 Screening in Dialysis Facilities
Sponsor: Stanford University
Industry payments
No payments involving this person were reported to CMS in program years 2021–2024. Why? →
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
100%Tetracycline-class Drug100%Doxycycline Hyclate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 21 Oct 2026
20 NIH research awards on record, funded 1991–2026 per NIH RePORTER. The latest:
- Consequences and mitigations of hyperthermia in Industrial Environments
Stanford University
FY2026$721,022R01DK146310 - Exploratory study of pesticide use and coccidioidomycosis
Stanford University
FY2026$194,855R21AI191179 - Exploratory study of pesticide use and coccidioidomycosis
Stanford University
FY2025$247,621R21AI191179
Publications
Updated 21 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Beyond Water, Rest, and Shade: Advancing Farmworker Heat Protection Through Partnership.
American journal of industrial medicine
Article2026 - Flush with data: harnessing emergency department wastewater as an innovative approach for surveillance of infectious diseases.
American journal of epidemiology
Article2026 - Use of Intrathecal Amphotericin for Coccidioidal Meningitis.
Open forum infectious diseases
Clinical Trial2025 - Implementing Oral Antibiotics for Bone and Joint Infections: Lessons Learned and Opportunities for Improvement.
Open forum infectious diseases
Clinical Trial2024
Most-cited works
by citation count (OpenAlex)- 01Helicobacter pylori Infection and the Risk of Gastric CarcinomaArticle3,894 citations1991
- 02Helicobacter pylori Infection and Gastric LymphomaArticle1,832 citations1994
- 03
- 04Helicobacter pylori Virulence and Genetic GeographyArticle1,049 citations1999
- 05
Network
Updated 21 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 21 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Editorial & leadership roles
journal and society appointments- Co-Founder
Board President, and Chair, SAFE
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →standsafe.org ↗ - Board of Directors
Doctors for America
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →med.stanford.edu ↗
- Fellow
Infectious Diseases Society of America
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
Secondary affiliations
appointments beyond the home institution- Board of Directors
Doctors for America
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Heather Wakelee, MD
Stanford University
Pamela Munster, MD
Stanford University
Martha Morrell, MD
Stanford University
Alexander Sandhu, MD
Stanford University
Eric Van Cutsem, MD, PhD
University Hospitals Leuven (UZ Leuven)
Josep Tabernero, MD, PhD
Vall d'Hebron Institute of Oncology (VHIO)
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
Charles Fuchs, MD, MPH
Tubulis GmbH